Table of Contents

Human plasma lipoprotein metabolism.
Regulation and clearance of apolipoprotein B-containing lipoproteins.
Absorption and excretion of intestinal cholesterol and other sterols.
High-density lipoprotein metabolism.
Lipoproteins : mechanisms for atherogenesis and progression of atherothrombotic disease.
Impact of rare and common genetic variants on lipoprotein metabolism.
Lipoprotein oxidation : mechanisms and biotheranostic applications.
Cholesterol : concentration, ratio, and particle number.
High-density lipoprotein cholesterol and triglycerides in coronary heart disease risk assessment.
Clinical evaluation for genetic and secondary causes of dyslipidemia.
Use of high-sensitivity c-reactive protein for risk assessment.
Role of lipoprotein-associated phospholipase A2 in vascular disease.
Emerging assays.
Imaging atherosclerosis for risk stratification by cardiac computed tomography or carotid ultrasound.
Overview of general approach to management of elevated low-density lipoprotein cholesterol and mixed dyslipidemia, high triglycerides, and low high-density lipoprotein cholesterol.
Treatment guidelines overview.
Dietary patterns for the prevention and treatment of cardiovascular disease.
Exercise and lipids.
Weight loss.
Bile acid sequestrants.
Cholesterol absorption inhibitors.
Niacin (nicotinic acid).
Omega-3 fatty acids.
Combination therapy for dyslipidemia.
Nutraceuticals and functional foods for cholesterol reduction.
Evolving targets of therapy : cholesteryl ester transfer protein inhibition.
Evolving targets of therapy : proprotein convertase subtilisin/kexin 9 inhibition.
Evolving targets of therapy : inflammation as a method to predict and prevent cardiovascular events.
Invasive imaging modalities and atherosclerosis : intravascular ultrasound.
Noninvasive imaging modalities and atherosclerosis : the role of ultrasound.
Noninvasive imaging modalities and atherosclerosis : the role of magnetic resonance imaging and positron emission tomography imaging.
Special patient populations : diabetes and metabolic syndrome.
Special patient populations : women and elderly.
Special patient populations : children and adolescents.
Special patient populations : familial hypercholesterolemia and other severe hypercholesterolemias.
Special patient populations : acute coronary syndromes.
Special patient populations : transplant recipients.
Special patient populations : chronic kidney disease.
Special patient populations : lipid abnormalities in high-risk ethnic groups.
Special patient populations : human immunodeficiency virus patients.
Therapeutic targeting of high-density lipoprotein metabolism. Clinical Lipidology, a companion to Braunwald's Heart Disease, is designed to guide you through the ever-changing therapeutic management of patients with high cholesterol levels. From basic science to pathogenesis of atherothrombotic disease, to risk assessment and the latest therapy options, this medical reference book offers unparalleled coverage and expert guidance on lipidology in a straightforward, accessible, and user-friendly style.
  • Get authoritative guidance from some of the foremost experts in the field.
  • Easily access key c.